<DOC>
	<DOCNO>NCT00305435</DOCNO>
	<brief_summary>The purpose study evaluate efficacy start dose AMG 531 measure platelet count cohort dose-escalation design .</brief_summary>
	<brief_title>Safety Study AMG 531 Japanese Subjects With ITP</brief_title>
	<detailed_description>The purpose study evaluate efficacy start dose AMG 531 measure platelet count cohort dose-escalation design .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<criteria>Japanese patient diagnosis ITP accord diagnostic criterion propose Research Committee Idiopathic Hematopoietic Disorders Ministry health , labor welfare Documented diagnosis arterial thrombosis previous year ; history venous thrombosis receive anticoagulation therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>AMG 531 , ITP , Phase 2 , Japanese</keyword>
</DOC>